Tower Research Capital LLC (Trc) Neuro Metrix, Inc. Transaction History

Tower Research Capital LLC (Trc)

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.61 - $0.98 $1,163 - $1,869	1,908 Added 95.93%	3,897 $2,000
Q2 2023 Aug 14, 2023	SELL	$0.92 - $1.48 $4,971 - $7,997	-5,404 Reduced 73.1%	1,989 $1,000
Q1 2023 May 09, 2023	BUY	$1.43 - $2.0 $872 - $1,220	610 Added 8.99%	7,393 $11,000
Q4 2022 Feb 10, 2023	BUY	$1.36 - $22.72 $8,929 - $149,179	6,566 Added 3025.81%	6,783 $10,000
Q3 2022 Nov 10, 2022	BUY	$2.97 - $23.6 $644 - $5,121	217 New	217 $1,000
Q2 2022 Aug 15, 2022	SELL	$2.81 - $5.5 $1,618 - $3,168	-576 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$3.42 - $6.37 $1,969 - $3,669	576 New	576 $2,000
Q4 2021 Feb 14, 2022	SELL	$5.02 - $9.82 $6,008 - $11,754	-1,197 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$3.23 - $24.73 $2,529 - $19,363	783 Added 189.13%	1,197 $12,000
Q2 2021 Aug 16, 2021	BUY	$2.72 - $3.8 $1,126 - $1,573	414 New	414 $1,000
Q1 2021 May 17, 2021	SELL	$3.01 - $5.35 $19,694 - $35,005	-6,543 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$1.5 - $3.64 $7,617 - $18,483	5,078 Added 346.62%	6,543 $21,000
Q3 2020 Nov 16, 2020	BUY	$1.48 - $2.26 $2,168 - $3,310	1,465 New	1,465 $2,000

320

Ticker NURO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 7,757,230
Market Cap $30.1M
Description
NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to e...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.